CD47 and breast carcinoma: Consistent with this observation, analysis of TCGA datasets using the GEPIA web tool (23) demonstrated that DNAJC13 expression is strongly and positively correlated with CD47 in several cancer types, particularly in breast cancer, melanoma, and colon cancer (Figure 2B).